MRI in Ductal Carcinoma in Situ (DCIS)

Relevance of Mammary MRI in the Preoperative Assessment of Ductal Carcinoma in Situ (DCIS)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03543397

Enrollment

Registered

2018-06-01

Start date

2018-02-26

Completion date

2019-02-28

Last updated

2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ductal Carcinomas

Keywords

ductal carcinomas, ductal carcinoma in situ (DCIS), MRI

Brief summary

Compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥18 ans * Woman with DCIS

Exclusion criteria

* Age ≥18 ans)

Design outcomes

Primary

Measure	Time frame	Description
The investigators compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size	The period from January 1st, 2017 to December 31st, 2017 will be examined]	Patients hospitalized at Strasbourg University Hospital in 2017

Countries

France

Contacts

Primary ContactMarie Noëlle ROEDLICH, MD

marie-noelle.roedlich@chru-strasbourg.fr33 3 88 12 78 42

Backup ContactClaire Dettloff, MD

claire.dettloff@chru-strasbourg.fr33 3 88 12 78 42

Outcome results